Progeria classification: Difference between revisions

Jump to navigation Jump to search
Line 24: Line 24:
|}
|}


* Other '''Non-progeroid laminopathies''' associated with ''LMNA'' gene mutations which produces atypical protein A lamin:<ref name="pmid20301609">{{cite journal| author=Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K et al.| title=GeneReviews® | journal= | year= 1993 | volume=  | issue=  | pages=  | pmid=20301609 | doi= | pmc= | url= }}</ref><ref name="pmid18513784">{{cite journal| author=Pereira S, Bourgeois P, Navarro C, Esteves-Vieira V, Cau P, De Sandre-Giovannoli A et al.| title=HGPS and related premature aging disorders: from genomic identification to the first therapeutic approaches. | journal=Mech Ageing Dev | year= 2008 | volume= 129 | issue= 7-8 | pages= 449-59 | pmid=18513784 | doi=10.1016/j.mad.2008.04.003 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18513784  }}</ref><ref name="pmid26948039">{{cite journal| author=Ikeda Y, Kumagai H, Motozawa Y, Suzuki J, Akazawa H, Komuro I| title=Understanding Vascular Diseases: Lessons From Premature Aging Syndromes. | journal=Can J Cardiol | year= 2016 | volume= 32 | issue= 5 | pages= 650-8 | pmid=26948039 | doi=10.1016/j.cjca.2015.12.003 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26948039  }}</ref>
* Other '''Non-progeroid laminopathies''' associated with ''LMNA'' gene mutations which produces atypical protein A lamin:<ref name="pmid20301609">{{cite journal| author=Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K et al.| title=GeneReviews® | journal= | year= 1993 | volume=  | issue=  | pages=  | pmid=20301609 | doi= | pmc= | url= }}</ref><ref name="pmid18513784">{{cite journal| author=Pereira S, Bourgeois P, Navarro C, Esteves-Vieira V, Cau P, De Sandre-Giovannoli A et al.| title=HGPS and related premature aging disorders: from genomic identification to the first therapeutic approaches. | journal=Mech Ageing Dev | year= 2008 | volume= 129 | issue= 7-8 | pages= 449-59 | pmid=18513784 | doi=10.1016/j.mad.2008.04.003 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18513784  }}</ref><ref name="pmid26948039">{{cite journal| author=Ikeda Y, Kumagai H, Motozawa Y, Suzuki J, Akazawa H, Komuro I| title=Understanding Vascular Diseases: Lessons From Premature Aging Syndromes. | journal=Can J Cardiol | year= 2016 | volume= 32 | issue= 5 | pages= 650-8 | pmid=26948039 | doi=10.1016/j.cjca.2015.12.003 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26948039 }}</ref><ref name="pmid12927431">{{cite journal| author=Chen L, Lee L, Kudlow BA, Dos Santos HG, Sletvold O, Shafeghati Y et al.| title=LMNA mutations in atypical Werner's syndrome. | journal=Lancet | year= 2003 | volume= 362 | issue= 9382 | pages= 440-5 | pmid=12927431 | doi=10.1016/S0140-6736(03)14069-X | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12927431 }}</ref>
** Emery-Dreifuss muscular dystrophy(Autosomal dominant)
** Emery-Dreifuss muscular dystrophy(Autosomal dominant)
** Emery-Dreifuss muscular dystrophy(Autosomal recessive)
** Emery-Dreifuss muscular dystrophy(Autosomal recessive)

Revision as of 15:29, 5 July 2019

Progeria Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Progeria from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Progeria classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Progeria classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Progeria classification

CDC on Progeria classification

Progeria classification in the news

Blogs on Progeria classification

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Progeria classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]

Overview

Progeria may be classified according to genotype into two groups:Classic progeria and atypical progeria.

Classification

  • Progeria may be classified according to genotype into two groups:
Classification of Hutchinson-Gilford Progeria Syndrome Cause
Group 1 Classic Hutchinson-Gilford progeria syndrome Due to nucleotide substitution in the lamin A/C gene LMNA(c.1824C>T [p.Gly608Gly])
Group 2 Atypical Hutchinson-Gilford progeria syndrome Due to variety of pathogenic variants in intron 11 of the LMNA gene
  • Other Non-progeroid laminopathies associated with LMNA gene mutations which produces atypical protein A lamin:[1][2][3][4]
    • Emery-Dreifuss muscular dystrophy(Autosomal dominant)
    • Emery-Dreifuss muscular dystrophy(Autosomal recessive)
    • Familial dilated cardiomyopathy(Autosomal dominant)
    • Dilated cardiomyopathy and hypergonadotropic hypogonadism
    • Dilated cardiomyopathy with apical left ventricular aneurysm(Autosomal dominant)
    • Mandibuloacral dysplasia(Autosomal recessive)
    • Restrictive dermopathy[5]
    • Familial partial lipodystrophy type 2
    • Dunnigan-type familial partial lipodystrophy (FPLD)
    • Limb-girdle muscular dystrophy[6]
    • Malouf syndrome with hypergonadotropic hypogonadism and cardiomyopathy

References

  1. Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K; et al. (1993). "GeneReviews®". PMID 20301609.
  2. Pereira S, Bourgeois P, Navarro C, Esteves-Vieira V, Cau P, De Sandre-Giovannoli A; et al. (2008). "HGPS and related premature aging disorders: from genomic identification to the first therapeutic approaches". Mech Ageing Dev. 129 (7–8): 449–59. doi:10.1016/j.mad.2008.04.003. PMID 18513784.
  3. Ikeda Y, Kumagai H, Motozawa Y, Suzuki J, Akazawa H, Komuro I (2016). "Understanding Vascular Diseases: Lessons From Premature Aging Syndromes". Can J Cardiol. 32 (5): 650–8. doi:10.1016/j.cjca.2015.12.003. PMID 26948039.
  4. Chen L, Lee L, Kudlow BA, Dos Santos HG, Sletvold O, Shafeghati Y; et al. (2003). "LMNA mutations in atypical Werner's syndrome". Lancet. 362 (9382): 440–5. doi:10.1016/S0140-6736(03)14069-X. PMID 12927431.
  5. McKenna T, Sola Carvajal A, Eriksson M (2015). "Skin Disease in Laminopathy-Associated Premature Aging". J Invest Dermatol. 135 (11): 2577–2583. doi:10.1038/jid.2015.295. PMID 26290387.
  6. Gallardo E, Saenz A, Illa I (2011). "Limb-girdle muscular dystrophy 2A". Handb Clin Neurol. 101: 97–110. doi:10.1016/B978-0-08-045031-5.00006-2. PMID 21496626.

Template:WH Template:WS